COMMUNIQUÉS West-GlobeNewswire

DBV Technologies Announces the Results of its 2026 Combined General Meeting
03/06/2026
Châtillon, France, June 3, 2026 DBV Technologies Announces the Results of its 2026 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq [...]
Main Results of 2026 Annual and Extraordinary General Meeting
03/06/2026
The 2026 Annual and Extraordinary General Meeting of Alvotech (the "2026 AGM") was held on June 3, 2026, at Arendt House, 41A Avenue John F. Kennedy, L-2082 Luxembourg. All of the draft resolutions on the 2026 AGM [...]
Booking Health Announces Release of Findings on International Access to Personalized Glioblastoma Treatment in Germany
03/06/2026
Langenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to personalized dendritic cell therapy for glioblastoma in Germany. [...]
Range Impact Announces $10 Million Investment from Tacora Capital
03/06/2026
CLEVELAND, OHIO, June 03, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing distressed coal mine properties [...]
GLP North Adds Retaject Availability to Its Canadian Research Catalogue
03/06/2026
TORONTO, June 04, 2026 (GLOBE NEWSWIRE) -- GLP North, a Canadian supplier focused on ready-to-use research pen formats, has added Retaject availability to its Canadian research catalogue. The listing expands the company [...]
OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration Document
03/06/2026
2025 Audited financial statements are consistent with Unaudited financial statements previously reported on April 30, 2026 The IRIS Financing announced on May 28, 2026, was added as a subsequent event Confirmed cash [...]
Annual General Meeting on June 24, 2026 Procedures for obtaining preparatory documents for the General Meeting
03/06/2026
NANTES, France, June 3, 2026 – 8:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (the "Company") , announced that it will hold its Annual General Meeting on June 24, 2026, at 10:00 am CET at Jones [...]
Assemblée Générale Mixte du 24 juin 2026 Modalités de mise à disposition des documents préparatoires à l’Assemblée
03/06/2026
NANTES, France, le 3 juin 2026, 20h00 CET – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) (la « Société ») , annonce la tenue de son Assemblée Générale Mixte le 24 juin 2026 à 10h00 dans les locaux du [...]
OSE Immunotherapeutics publie ses résultats financiers consolidés audités pour l’exercice 2025 et annonce le dépôt de son Document d’Enregistrement Universel 2025
03/06/2026
OSE Immunotherapeutics publie ses résultats financiers consolidés audités pour l’exercice 2025 et annonce le dépôt de son Document d’Enregistrement Universel 2025 Les résultats financiers consolidés audités 2025 sont en [...]
Medical Grade Physiotherapy & Wellness Now Accepting New Clients in Burlington, Ontario — Redefining One-on-One Rehabilitation & Wellness Care
03/06/2026
BURLINGTON, Ontario, June 03, 2026 (GLOBE NEWSWIRE) -- Located in the heart of Burlington, Ontario, Medical Grade Physiotherapy & Wellness is proud to announce the that it is officially accepting new clients in its [...]
Porch Light Health Launches Porch Light Health University to Expand Access to Practical Addiction Medicine Training
03/06/2026
DENVER, June 03, 2026 (GLOBE NEWSWIRE) -- Porch Light Health today announced the launch of Porch Light Health University (PLHU), a new educational platform designed to equip healthcare professionals with practical, real [...]
Curiox Automates Flow Cytometry Sample Prep End-to-End on a Single Instrument
03/06/2026
New software for Pluto Workstation automates cocktailing, staining, and centrifuge-free washing — running the lab’s existing SOP without coding or instrument handoff. Validated at Stanford HIMC and Dana-Farber. [...]
Cadrenal Therapeutics to Showcase Phase 3-Ready CAD-1005 and Novel 12-LOX Platform at BIO International Convention 2026 Partnering Event
03/06/2026
Lead asset CAD-1005 being researched for prevention of life-threatening blood clots in patients with Heparin-induced Thrombocytopenia (HIT), targets $2 billion peak annual revenue potential 12-LOX could play a central [...]
JenaValve Appoints Maria Jose Arana as Vice President of Quality and Compliance
03/06/2026
IRVINE, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of Maria Jose Arana as [...]
LiveWorld Launches LiveInsight AI™, Creating a New Category of Intelligence Systems for Pharma
03/06/2026
With 12 patents pending, the Human-Led, AI-Powered system delivers decision-grade insights — customized by disease state, brand, and user — in minutes, not weeks CAMPBELL, Calif. and NEW YORK, June 03, 2026 (GLOBE [...]
MAIA Biotechnology Receives FDA Clearance to Open U.S. Enrollment in Ongoing Phase 2 THIO-101 Trial Expansion
03/06/2026
Additional data from THIO-101 trial expansion studies may further support a potential Accelerated Approval filing with FDA FDA-cleared IND updates detail latest efficacy data and enriched manufacturing protocols CHICAGO [...]
NYC Physician Dr. Felix Cohen Expands Access to Advanced Treatment for Women Suffering from Abnormal Uterine Bleeding and Dysmenorrhea
03/06/2026
Cerene Cryotherapy Now Available in Queens NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Channel Medsystems, a leader in women’s health innovation, is pleased to announce that Dr. Felix Cohen, M.D., FACOG, Medical [...]
OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network
03/06/2026
Network Expands to More Than 2,300 Healthcare Partner Sites, Advancing the Company's Strategic Network-Growth MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “ [...]
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
03/06/2026
Clinically meaningful, statistically significant efficacy achieved in primary and all secondary endpoints, including reduced steroid use; safety consistent with established Cosentyx profile 1,2 Polymyalgia rheumatica ( [...]

Pages